Intracellular delivery of nanoparticles via the HIV-1 tat peptide.
about
Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimagingCell-penetrating peptides: possibilities and challenges for drug delivery in vitro and in vivoAnti-HIV-1 nanotherapeutics: promises and challenges for the futureGold nanoparticles delivery in mammalian live cells: a critical reviewSurface presentation of functional peptides in solution determines cell internalization efficiency of TAT conjugated nanoparticlesHIV-1 neuroimmunity in the era of antiretroviral therapy.The potential of nanomedicine therapies to treat neovascular disease in the retina.Electrochemical impedimetric biosensor based on a nanostructured polycarbonate substrate.Beyond the imaging: limitations of cellular uptake study in the evaluation of nanoparticles.Tat peptide-decorated gelatin-siloxane nanoparticles for delivery of CGRP transgene in treatment of cerebral vasospasmPolydopamine-based surface modification for the development of peritumorally activatable nanoparticlesSynthesis, characterization, and direct intracellular imaging of ultrasmall and uniform glutathione-coated gold nanoparticlesEnhancing cancer immunotherapy by intracellular delivery of cell-penetrating peptides and stimulation of pattern-recognition receptor signaling.Targeted hyperthermia using metal nanoparticles.Molecular imaging with SERS-active nanoparticles.Inspired by nature: fundamentals in nanotechnology design to overcome biological barriers.Nanoparticle-Based Delivery of RNAi Therapeutics: Progress and Challenges.Lymphatic system: a prospective area for advanced targeting of particulate drug carriers.A novel branched TAT(47-57) peptide for selective Ni(2+) introduction into the human fibrosarcoma cell nucleus.Electroporation-based delivery of cell-penetrating peptide conjugates of peptide nucleic acids for antisense inhibition of intracellular bacteria.Design, synthesis and characterization of a new anionic cell-penetrating peptide: SAP(E).Selective inhibition of human brain tumor cells through multifunctional quantum-dot-based siRNA delivery.Liposome armed with herpes virus-derived gH625 peptide to overcome doxorubicin resistance in lung adenocarcinoma cell lines.Structural Basis for Importin-α Binding of the Human Immunodeficiency Virus Tat.Encapsulation of gold nanoparticles into self-assembling protein nanoparticles.Elucidating the function of penetratin and a static magnetic field in cellular uptake of magnetic nanoparticles.Peptide amphiphile nanoparticles enhance the immune response against a CpG-adjuvanted influenza antigen.Cell-penetrating HIV1 TAT peptides can generate pores in model membranes.The effect of cell penetrating peptides on transfection activity and cytotoxicity of polyallylamine.Gold nanoparticle-siRNA mediated oncogene knockdown at RNA and protein level, with associated gene effects.Biological effects of Tat cell-penetrating peptide: a multifunctional Trojan horse?Protamine-Capped Mesoporous Silica Nanoparticles for Biologically Triggered Drug Release“Clicking” Porphyrins to Magnetic Nanoparticles for Photodynamic TherapyEfficient internalization and intracellular translocation of inhaled gold nanoparticles in rat alveolar macrophages
P2860
Q21223671-D1EB18CA-CFA7-40CD-9A18-2BA0B2BFFE13Q26800100-50E15371-54B7-4F5D-8CFD-8A95CAEA1BCFQ26828464-2921F5AC-76D3-46DA-9D2A-EFCB808B282CQ30472806-A4D72A3A-7717-4DAD-8CA5-43CFBE1282B5Q33614043-169D0B28-BD6A-4009-8DF6-24F73F810144Q33733529-167DB0DC-2D76-4691-8139-48126BAF5112Q34220590-8B2B9CCA-1B0D-4852-B08B-9F2F4098708AQ35679874-5313CBEA-86FA-4BDE-BDBE-D65EF4853DEEQ36247616-6C300297-15CE-4637-AD46-3A68FCD049E2Q36743652-31D96241-91BB-4697-A87F-D9ED887865A1Q36979875-C12520E1-DA30-4EA9-90CB-C600E41E21C8Q37025215-F12F3B03-F2EB-477E-9BD0-20BBAFC18F7AQ37139813-0A573602-C831-4E51-A937-1C139EAB2337Q37631871-D4010F36-EA69-4482-88C1-41521F8806BBQ37935679-8A15FE66-DD2E-49EB-BEF3-BD08E2C515AAQ38074461-C8FD998F-3424-40F2-AD48-41567DD4BBDEQ38106032-07A0CCF9-C067-4559-9A6C-F8B3971FE194Q38172276-38FFD5D0-90FF-4287-8C0B-E03C91D8C45DQ38880594-7519089E-103F-4EEE-AC47-CD1FBE83A91FQ38962523-8664638E-0D21-4439-BFEE-538D46BACCD8Q39583280-57002380-1D57-4B55-B447-3D22B97B6297Q39768994-86A89C62-A6B1-47B4-AFDF-1E79D51AAA1BQ39996592-EF43011C-3841-49B9-9673-CB170211649EQ40057606-D666806F-4AAD-4E31-A8AD-EB3B0CA44FE1Q41602456-456599CD-9CA5-4360-86AD-09BFC2759CA2Q41998121-1185EA36-61E9-433E-BEE4-CE965311E6B4Q42273780-FEACB26A-06CD-40BE-8B2F-C360F8B00A00Q42739622-32092A63-58E8-4374-89AE-8BAAD63592CBQ46236828-ED0E230B-2778-4FC8-AEC0-1B124B3B0292Q51797664-23A91922-EB11-427E-9DD7-E088ED1714E1Q51855277-8BFA3A3A-9B60-47C1-A43A-B19DCA64B1CFQ57173204-C3C26674-CC50-411F-A0CB-5E2308FBFF79Q58034978-2C3A3A18-6DD6-4574-BC91-E90FF143A829Q58233186-58897A47-B5C9-4271-B1D5-B93AF6F0FA89
P2860
Intracellular delivery of nanoparticles via the HIV-1 tat peptide.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Intracellular delivery of nanoparticles via the HIV-1 tat peptide.
@en
Intracellular delivery of nanoparticles via the HIV-1 tat peptide.
@nl
type
label
Intracellular delivery of nanoparticles via the HIV-1 tat peptide.
@en
Intracellular delivery of nanoparticles via the HIV-1 tat peptide.
@nl
prefLabel
Intracellular delivery of nanoparticles via the HIV-1 tat peptide.
@en
Intracellular delivery of nanoparticles via the HIV-1 tat peptide.
@nl
P2860
P356
P1433
P1476
Intracellular delivery of nanoparticles via the HIV-1 tat peptide.
@en
P2093
P2860
P304
P356
10.2217/17435889.3.3.357
P577
2008-06-01T00:00:00Z